An Ab­b­Vie clin­i­cal vet head­ing ear­ly on­col­o­gy jumps ship to build his own team at NK cell-fo­cused biotech

Mak­ing the leap from a mid-sized biotech in­to the ranks of phar­ma can be a chaf­ing ex­pe­ri­ence for ex­ec­u­tives used to a more flex­i­ble work en­vi­ron­ment — and that jump gets even hard­er dur­ing an ac­qui­si­tion. For Thorsten Graef, a clin­i­cal vet­er­an who tran­si­tioned from Phar­ma­cyclics in­to Ab­b­Vie, the move was a learn­ing ex­pe­ri­ence in terms of what sort of team he want­ed to run.

Now, he’s get­ting his chance.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER